Cabot Wellington, LLC Pfizer Inc Transaction History

Cabot Wellington, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Mar 21, 2023	SELL	$43.76 - $53.42 $211,448 - $258,125	-4,832 Closed	0 $0
Q2 2022 Mar 21, 2023	SELL	$46.53 - $55.17 $170,485 - $202,142	-3,664 Reduced 43.13%	4,832 $253 Million
Q3 2021 Dec 30, 2021	SELL	$39.25 - $50.42 $25,669 - $32,974	-654 Reduced 7.15%	8,496 $365,000
Q3 2020 Dec 07, 2020	BUY	$31.75 - $37.25 $4,762 - $5,587	150 Added 1.67%	9,150 $336,000
Q1 2018 May 21, 2018	BUY	$31.91 - $37.02 $287,190 - $333,180	9,000 New	9,000 $319,000

3,260

3.73B

73.5M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cabot Wellington, LLC, based on Form 13F filings with the SEC.

Stay updated on Cabot Wellington, LLC with notifications on news.